Gemcitabine, fludarabine and melphalan as a reduced-intensity conditioning regimen for allogeneic stem cell transplant in relapsed and refractory Hodgkin lymphoma: preliminary results
2010 ◽
Vol 51
(8)
◽
pp. 1502-1508
◽
2012 ◽
Vol 18
(2)
◽
pp. S213
2015 ◽
Vol 21
(2)
◽
pp. S331-S332
2012 ◽
Vol 8
(3)
◽
pp. 255-267
◽
2014 ◽
Vol 20
(2)
◽
pp. S233
2013 ◽
Vol 55
(2)
◽
pp. 296-306
◽
2018 ◽
Vol 184
(5)
◽
pp. 840-844
◽
2016 ◽
Vol 22
(3)
◽
pp. S265